SG/PUT/PFIZER INC/30/0.1/20.12.24 | Market Closed - Boerse Frankfurt Warrants 20:42:29 05/07/2024 BST | ||
| 0.3 EUR | 0.00% |
|
| Current month | -6.45% | ||
| 1 month | +26.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 0.29 | -3.33% |
| 04/07/24 | 0.3 | -6.25% |
| 03/07/24 | 0.32 | +3.23% |
| 02/07/24 | 0.31 | +6.90% |
| 01/07/24 | 0.29 | -6.45% |
Real-time Boerse Frankfurt Warrants
Last update July 05, 2024 at 08:42 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| WKN | SU2731 |
| ISIN | DE000SU27315 |
| Date issued | 05/12/2023 |
| Strike | 30 $ |
| Maturity | 20/12/2024 (168 Days) |
| Parity | 10 : 1 |
| Emission price | 0.36 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.53 € |
|---|---|
| Lowest since issue | 0.22 € |
| Spread | 0.01 € |
| Spread % | 3.33% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.05
USD
Average target price
31.92
USD
Spread / Average Target
+13.78%
- Stock Market
- Warrants
- Warrant
